This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Goldgene LLC. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Patricio Craig: Innovator in Chimeric Protein Technology
Introduction
Patricio Craig is a notable inventor based in Buenos Aires, Argentina. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric proteins. His innovative work has led to advancements in various applications, including vaccines and pharmaceutical compounds.
Latest Patents
Patricio Craig holds a patent for "Isolated chimeric proteins of modified lumazine synthase." This patent encompasses isolated chimeric proteins that include up to ten copies of peptides, polypeptides, or protein domains inserted in the amino termini of the lumazine synthase enzyme. The patent also covers isolated nucleotide sequences that code for these chimeric proteins, as well as vectors, plasmids, and transformed cells used for expressing the proteins. Additionally, it includes monoclonal and polyclonal antibodies induced by the chimeric proteins, hybridomas producing these antibodies, and various applications such as vaccines and pharmaceutical compounds that incorporate the chimeric proteins, nucleotide sequences, and antibodies. The patent outlines a method to induce an immune response in higher organisms through the administration of effective amounts of the vaccines and pharmaceutical compounds. Furthermore, it discusses biosensors that utilize the chimeric proteins and protein conjugates formed by the chimeric proteins and a ligand bound by covalent and noncovalent bonds.
Career Highlights
Patricio Craig is currently associated with Goldgene LLC, where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential impact on medical and pharmaceutical applications. With a focus on chimeric proteins, Craig's research is paving the way for new therapeutic solutions.
Collaborations
Throughout his career, Patricio Craig has collaborated with esteemed colleagues, including Carlos Alejandro Velikovsky and Carlos Alberto Fossati. These collaborations have contributed to the advancement of his research and the successful development of innovative technologies.
Conclusion
Patricio Craig is a pioneering inventor whose work in chimeric protein technology is making significant strides in biotechnology. His contributions are expected to have lasting effects on the development of vaccines and therapeutic compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile